References
- Akamatsu S, Yazawa S, Tachikawa T. 1996. a-2-3 Sialyltransferase associated with synthesis of CA 19-9 in colorectal tumors. Cancer 77:7–9.
- Balasenthil S, Arivazhagan S, Ramachandran CR, Ramachandran V, Nagini S. 1999. Chemopreventive potential of neem (Azadirachta indica) on 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinogenesis. J Ethnopharmacol 67:189–195.
- Berdowska I. 2004. Cysteine proteases as disease markers. Clin Chem Acta 342:41–69.
- Burger MM, Goldberg A. 1967. Identification of a tumor-specific determinant on neoplastic cell surfaces. Proc Natl Acad Sci USA 57:359–366.
- Cannell DW, Sadeeva N, Mathur H, Nguyen NV. 2001. The use of plant extract in a cosmetic composition to protect keratinous fibers. Available online at: http://ww.wipo.int/ Accessed 6 February 2008.
- Cumar FA, Brady RO, Kolodny EH, McFarland VW, Mora PT. 1970. Enzymatic block in the synthesis of gangliosides in DNA virus-transformed tumorigenic mouse cell lines. Proc Natl Acad Sci USA 67:757–764.
- Dani V, Goel A, Vaiphei K, Dhawan DK. 2007. Chemopreventive potential of zinc in experimentally induced colon carcinogenesis. Toxicol Lett 171:10–18.
- Davidsohn I, Kovarik S, Lee CL. 1966. A, B, and 0 substances in gastrointestinal carcinoma. Arch Pathol 81:381–390.
- De Albuquerque Garcia Redondo P, Nakamura CV, de Souza W, Morgado-Díaz JA. 2004. Differential expression of sialic acid and N-acetylgalactosamine residues on the cell surface of intestinal epithelial cells according to normal or metastatic potential. J Histochem Cytochem 52:629–640.
- Dudeja PK, Brasitus TA. 1990. 2-Dimethylhydrazine-induced alterations in lipid peroxidation in preneoplastic and neoplastic colonic tissues. Biochim Biophys Acta 1046:267–270.
- Fishman PH, Brady RO, Bradley RM, Aronson SA, Todaro GJ. 1974. Absence of a specific ganglioside galactosyltransferase in mouse cells transformed by murine sarcoma virus. Proc Natl Acad Sci USA 71:298–301.
- Gold P, Gold M, Freedman S. 1968. Cellular location of carcino embryonic antigens of the human digestive system. Cancer Res 28:1331–1334.
- Goodarzi MT, Shafiei M, Nomani H, Shahriarahmadi A. 2005. Relationship between total and lipid-bound serum sialic acid and some tumor markers. Iran J Med Sci 30:124–127.
- Hakomori S. 1970. Cell density-dependent changes of glycolipid concentrations in fibroblasts and loss of this response in virus-transformed cells. Proc Natl Acad Sci USA 67:1741–1747.
- Katopodis N, Hirshaut Y, Geller NL. 1982. Lipid-associated serum sialic acid test for the detection of human cancer. Cancer Res 42:5270–5275.
- Katopodis N, Stock CC. 1980. Improved method to determine lipidbound sialic acid in plasma serum. Res Commun Chem Path Pharmacol 30:171–180.
- LaMont JT, O’Gorman TA. 1978. Experimental colon cancer. Gastroenterology 75:1157–1169.
- Laterz OF, Price CP, Scott MG. 2002. Cystatin C an improved estimator of glomerular filtration rate. Clin Chem 48:699–707.
- Lewis CL, Brenner AT, Griffith JM, Pignone MP. 2008. The uptake and effect of a mailed multi-modal colon cancer screening intervention: a pilot controlled trial. Implement Sci 3:32.
- Li CJ, Wang C, Pardee AB. 1995. Induction of apoptosis by beta-lapachone in human prostate cancer cells. Cancer Res 55:3712–3715.
- Lopez Saez JJ, Senra-Varela A. 1995. Evaluation of lipid-bound sialic acid (LASA) as a tumor marker. Int J Biol Markers 10:174–179.
- Mandal-Ghosh I, Chattopadhyay U, Baral R. 2007. Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen. Cancer Immun 30:7–8.
- Miyazaki K, Ohmori K, Izawa M. 2004. Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res 64:4498–4505.
- Mora PT, Fishman PH, Bussin RH, Brady RO, McFarland VW. 1973. Transformation of Swiss 3T3 cells by murine sarcoma virus is followed by decrease in a glycolipid glycosyl transferase. Nature New Biol 245:226–229.
- Painbeni T, Gamelin E, Cailleux A. 1997. Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer. Eur J Cancer 33:2216–2220.
- Pokorny RM, Hunt L, Galandiuk S. 2000. What’s new with tumor markers for colorectal cancer? Dig Surg 17:209–215.
- Romppanen J, Petaja J, Heikinheimo M. 1998. Total and lipid-bound serum sialic acid in children with malignancy or infections. Anticancer Res 18:2793–2797.
- Sameni M, Moin K, Sloane BF. 2000. Imaging proteolysis by living human breast cancer cells. Neoplasia 2:496–504.
- Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. 1999. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20:1425–1431.
- Stellner K, Hakomori S. 1973. Enzymatic conversion of H1-glycolipid to A- or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma. Biochem Biophys Res Commun 55:439–445.
- Waters PJ, Lewry E, Pennock CA. 1992. Measurement of sialic acid in serum and urine: clinical applications and limitations. Ann Clin Biochem 29:625–637.
- Weisburger JH. 1971. Colon carcinogens: their metabolism and mode of action. Cancer 28:60–70.